Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non-small-cell lung cancer

被引：0
|
作者：
Naidoo, Jarushka
Johnson, Douglas Buckner
Doran, Charlotte
Wang, Yuexi
Zhang, Yan
Le, Trong Kim
Hopson, Sari
Dreyfus, Brian
Lal, Lincy S.
Vyas, Charmy
Goldstein, Shay
Izadi, Zara
机构：
[1] Beaumont RCSI Canc Ctr, Dublin, Ireland
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] ConcertAI, Cambridge, MA USA
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6604
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors
    Horstman, I. M.
    Vinke, P. C.
    Suazo-Zepeda, E.
    Hiltermann, T. J. N.
    Heuvelmans, M. A.
    Corpeleijn, E.
    de Bock, G. H.
    THORACIC CANCER, 2024, 15 (23) : 1764 - 1771
  • [2] Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer
    Kichenadasse, Ganessan
    Miners, John O.
    Mangoni, Arduino A.
    Rowland, Andrew
    Hopkins, Ashley M.
    Sorich, Michael J.
    JAMA ONCOLOGY, 2020, 6 (04) : 512 - 518
  • [3] Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor
    Kubo, Sousuke
    Kobayashi, Nobuaki
    Somekawa, Kohei
    Hirata, Momo
    Kamimaki, Chisato
    Aiko, Hiroko
    Katakura, Seigo
    Teranishi, Shuhei
    Watanabe, Keisuke
    Hara, Yu
    Yamamoto, Masaki
    Kudo, Makoto
    Kaneko, Takeshi
    ANTICANCER RESEARCH, 2020, 40 (07) : 3889 - 3896
  • [4] Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer
    Mountzios, G.
    Samantas, E.
    Senghas, K.
    Zervas, E.
    Krisam, J.
    Samitas, K.
    Bozorgmehr, F.
    Kuon, J.
    Agelaki, S.
    Baka, S.
    Athanasiadis, I.
    Gaissmaier, L.
    Elshiaty, M.
    Daniello, L.
    Christopoulou, A.
    Pentheroudakis, G.
    Lianos, E.
    Linardou, H.
    Kriegsmann, K.
    Kosmidis, P.
    El Shafie, R.
    Kriegsmann, M.
    Psyrri, A.
    Andreadis, C.
    Fountzilas, E.
    Heussel, C. -P.
    Herth, F. J.
    Winter, H.
    Emmanouilides, C.
    Oikonomopoulos, G.
    Meister, M.
    Muley, T.
    Bischoff, H.
    Saridaki, Z.
    Razis, E.
    Perdikouri, E. -I.
    Stenzinger, A.
    Boukovinas, I.
    Reck, M.
    Syrigos, K.
    Thomas, M.
    Christopoulos, P.
    ESMO OPEN, 2021, 6 (05)
  • [5] Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
    Li Nijiao
    Zheng Xuliang
    Gan Jinyan
    Zhuo Ting
    Li Xiaohong
    Yang Chuyi
    Wu Yanbin
    Qin Shouming
    中华医学杂志(英文版), 2023, 136 (21)
  • [6] Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors
    Li, Nijiao
    Zheng, Xuliang
    Gan, Jinyan
    Zhuo, Ting
    Li, Xiaohong
    Yang, Chuyi
    Wu, Yanbin
    Qin, Shouming
    CHINESE MEDICAL JOURNAL, 2023, 136 (21) : 2562 - 2572
  • [7] Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer
    Miyawaki, Taichi
    Kenmotsu, Hirotsugu
    Mori, Keita
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Harada, Hideyuki
    Endo, Masahiro
    Ohde, Yasuhisa
    Takahashi, Kazuhisa
    Takahashi, Toshiaki
    CLINICAL LUNG CANCER, 2020, 21 (05) : E405 - E414
  • [8] Association of Opioid Use with Survival in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitor Therapy
    Mock, J.
    Wynter, E.
    Young, P.
    Sytov, A.
    Elghawy, O.
    Gentzler, R.
    Novicoff, W.
    Martin, L.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S20 - S21
  • [9] Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
    Zeng, Yue
    Hu, Chun-Hong
    Li, Yi-Zheng
    Zhou, Jian-Song
    Wang, Shu-Xing
    Liu, Meng-Dong
    Qiu, Zhen-Hua
    Deng, Chao
    Ma, Fang
    Xia, Chun-Fang
    Liang, Fei
    Peng, Yu-Rong
    Liang, Ao-Xi
    Shi, Sheng-Hao
    Yao, Shi-Jiao
    Liu, Jun-Qi
    Xiao, Wen-Jie
    Lin, Xiao-Qiao
    Tian, Xin-Yu
    Zhang, Ying-Zhe
    Tian, Zhuo-Ying
    Zou, Ji-An
    Li, Yun-Shu
    Xiao, Chao-Yue
    Xu, Tian
    Zhang, Xiao-Jie
    Wang, Xiao-Ping
    Liu, Xian-Ling
    Wu, Fang
    NATURE MEDICINE, 2024, : 1680 - 1688
  • [10] Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer Reply
    Passaro, Antonio
    Spitaleri, Gianluca
    de Marinis, Filippo
    CLINICAL LUNG CANCER, 2020, 21 (05) : E415 - E416
12345